A phase 1/2a, dose-escalation, safety, and preliminary efficacy study of the RKP00156 vaginal tablet in healthy women and patients with cervical intraepithelial neoplasia 2.
Hyun Woong ChoSohyeon JeongSeung Hun SongYoung-Tae KimJae-Weon KimChi Heum ChoSoo Young HurSuk-Joon ChangYong-Man KimJae Kwan LeePublished in: Journal of gynecologic oncology (2024)
ClinicalTrials.gov Identifier: NCT02139267.